PAX2 Polyclonal antibody

PAX2 Polyclonal Antibody for WB,ELISA

Host / Isotype

Rabbit / IgG

Reactivity

Human, mouse, rat and More (1)

Applications

WB, IHC, FC, ELISA

Conjugate

Unconjugated

Publications

2

Cat no : 29307-1-AP

Synonyms

paired box 2, Paired box protein Pax 2, PAX2

---

Validation Data Gallery

• 

  WB analysis using 29307-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 29307-1-AP (PAX2 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

---

Tested Applications

• Positive WB detected in: mouse cerebellum tissue, rat cerebellum tissue

Recommended dilution

• Western Blot (WB): WB : 1:500-1:2000

Sample-dependent, check data in validation data gallery

Published Applications

• IHC: See 1 publications below
• FC: See 1 publications below

Product Information

29307-1-AP targets PAX2 in WB, IHC, FC, ELISA applications and shows reactivity with Human, mouse, rat samples.

• Tested Reactivity: Human, mouse, rat
• Cited Reactivity: human
• Host / Isotype: Rabbit / IgG
• Class: Polyclonal
• Type: Antibody
• Immunogen: PAX2 fusion protein Ag30717
• Full Name: paired box 2
• Calculated molecular weight: 431 aa, 46 kDa
• Observed molecular weight: 45 kDa
• GenBank accession number: BC148710
• Gene symbol: PAX2
• Gene ID (NCBI): 5076
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Antigen affinity purification
• Storage Buffer: PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
• Storage Conditions: Store at -20°C. Aliquoting is unnecessary for -20^oC storage.

Background Information

PAX2 is a transcription factor, primarily expressed during embryonic development. It has a critical role in the development of the urogenital tract, the eyes, and the CNS. It plays a key role during renal development and to act as an oncogene favoring renal tumor growth. PAX2 was suggested as a sensitive and highly specific marker for renal cell carcinoma (RCC).

Publications

Species	Application	Title
human	FC	Cells; Human iPSC-Derived Renal Cells Change Their Immunogenic Properties during Maturation: Implications for Regenerative Therapies.; Authors - Bella Rossbach
human	IHC	Sci Bull (Beijing); Reprogramming of Ovarian Granulosa Cells by YAP1 Leads to Development of High-Grade Cancer with Mesenchymal Lineage and Serous Features.; Authors - Xiangmin Lv